Synovial Sarcoma Prognostic Factors and Patterns of Failure

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 2, 2004, Pages 122-127

  Paulino, Arnold C ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b EMORY CLINIC   (United States)

Author keywords

Distant metastasis; Patterns of failure; Prognostic factors; Synovial sarcoma

Indexed keywords

CARBOPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADOLESCENT; ADULT; AGE; AGED; AMPUTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIMB SALVAGE; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PREDICTION; PROGNOSIS; SYNOVIAL SARCOMA; TREATMENT FAILURE; TUMOR LOCALIZATION; TUMOR VOLUME; UNITED STATES; UNIVERSITY;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SARCOMA, SYNOVIAL; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 1842529264     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000047130.91699.DC     Document Type: Article

References (21)

1. Dillon P, Maurer H, Jenkins J, et al. A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group. J Pediatr Surg 1992;27:241-5.
2. Horowitz ME, Pratt CB, Webber BL, et al. Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcomas: a review of 62 cases treated at a single institution. J Clin Oncol 1986;4:559-64.
3. Pappo AS, Fontanesi J, Luo X, et al. Synovial sarcoma in children and adolescents: the St. Jude Children's Research Hospital experience. J Clin Oncol 1994;12:2660-6.
4. Ladenstein R, Treuner J, Koscielniak E, et al. Synovial sarcoma of childhood and adolescence: report of the German CWS-81 study. Cancer 1993;71:3647-55.
5. Hashimoto H. Incidence of soft tissue sarcomas in adults. Curr Top Pathol 1995;89:1-16.
6. Lawrence W, Donegan WL, Natarajan N, et al. Adult soft tissue sarcomas. Ann Surg 1987;205:349-59.
7. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-81.
8. Cox DR. Regression models and life tables (with discussion). JR Stat Soc B 1972;34:187-220.
9. SAS System for Windows. Version 8.0. Cary, NC: SAS Institute Inc., 1999.
10. Allison PD. Survival analysis using the SAS system: a practical guide. Cary, NC: SAS Institute Inc., 1995.
11. Andrassy RJ, Okcu MF, Despa S, et al. Synovial sarcoma in children: surgical lessons from a single institution and review of the literature. J Am Coll Surg 2001;192:305-13.
12. Ferrari A, Casanova M, Massimino M, et al. Synovial sarcoma: report of 25 consecutive children from a single institution. Med Pediatr Oncol 1999;32:32-7.
13. Fontanesi J, Pappo AS, Parham DM, et al. Role of irradiation in management of synovial sarcoma: St. Jude Children's Research Hospital experience. Med Pediatr Oncol 1996;26:264-7.
14. Thompson RC, Garg A, Goswitz J, et al. Synovial sarcoma: large size predicts poor outcome. Clin Orthop 2000;373:18-24.
15. Bergh P, Meis-Kindblom JM, Gherlinzoni F, et al. Synovial sarcoma: identification of low and high-risk groups. Cancer 1999;85:2596-607.
16. Meis-Kindblom JM, Enzinger FM. Color atlas of soft tissue tumors. St. Louis: Mosby-Wolfe, 1996;189-200.
17. Singer S, Baldini EH, Demetri GD, et al. Synovial sarcoma: prognostic significance of tumor size, margin of resection and mitotic activity for survival. J Clin Oncol 1996;14:1201-8.
18. Mullen JR, Zagars GK. Synovial sarcoma outcome following conservation surgery and radiotherapy. Radiother Oncol 1994;33:23-30.
19. Cagle LA, Mirra JM, Storm FK, et al. Histologic features relating to prognosis in synovial sarcoma. Cancer 1987;59:1810-4.
20. Ogose A, Morita T, Hotta T, et al. Brain metastases in musculoskeletal sarcomas. Jpn J Clin Oncol 1999;29:245-7.
21. Parasuraman S, Langston J, Rao BN, et al. Brain metastases in pediatric Ewing sarcoma and rhabdomyosarcoma: the St. Jude Children's Research Hospital experience. J Pediatr Hematol Oncol 1999;21:370-7.